Novel enantiomerically pure betaagonists, method for their production and their use as medicaments

Details for Australian Patent Application No. 2007224420 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sieger, Peter; Ries, Uwe

Agent Davies Collison Cave

Pub. Number AU-A-2007224420

PCT Pub. Number WO2007/104772

Priority 06111342.9 17.03.06 EP; 06111338.7 17.03.06 EP; 06111191.0 15.03.06 EP

Filing date 14 March 2007

Wipo publication date 20 September 2007

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/538 (2006.01)

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/104772 Priority application(s): WO2007/104772

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224430-Recombinant Newcastle disease virus expressing H5 hemagglutinin of avian influenza virus

2007224419-Orodispersible domperidone tablets